Maintaining Weight Loss Continuing semaglutide treatment helps sustain weight loss and prevents weight regain while adhering to healthy lifestyle habits
Although it is not yet widely recognized for this use, initial studies and hypotheses suggest it could have a beneficial impact
In the OASIS clinical trial, the oral version of semaglutide was initiated with a 3 mg dose which was titrated every four weeks to 7mg, 14mg, then a final dose of 25mg, however the initial dose of the Wegovy Pill will be 1.5mg
GLP-1 receptor agonists may lead to weight loss
Testing small behavior changes over two-week periods can reveal practical, easy-to-measure, repeatable changes
Coffee intake can also influence food intake, eating habits, and appetite regulation, which are important factors for those trying to support weight management or lose weight